Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Effect of OC000459 on Signs and Symptoms in Subjects With Moderate to Severe Atopic Dermatitis: A Randomised Double Blind Placebo Controlled Parallel Group Study

NCT02002208 is registered in ClinicalTrials.gov with Atopix Therapeutics, Ltd. as lead sponsor.

NCT NCT02002208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02002208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Effect of OC000459 on Signs and Symptoms in Subjects With Moderate to Severe Atopic Dermatitis: A Randomised Double Blind Placebo Controlled Parallel Group Study
Lead sponsor
Atopix Therapeutics, Ltd.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
February 29, 2016
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis